{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 22,
        "end": 28
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 76,
        "end": 80
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 76,
        "end": 98
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 195,
        "end": 199
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 138,
        "end": 149
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 203,
        "end": 211
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23302800_3",
  "text": "Moreover , the marked tumour regression and improved survival of late-stage BRAF -mutated melanoma patients in response to treatment with vemurafenib demonstrates the essential role of oncogenic BRAF in melanoma maintenance ."
}
